Alpha Diallo
0
All posts from Alpha Diallo
Alpha Diallo in Alpha Diallo,

Lexicon Pharmaceuticals Soaring on Successful Clinical Trial for Type 1 Diabetes

 (Image source: diabeticlive.com)

Shares of the biopharmaceutical company Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are soaring this morning after the company announced positive results for its Phase 2 clinical trial of the experimental diabetes drug LX4211. LX4211 is used to treat patients with type 1 diabetes. In the clinical trial, LX4211 was successful at reducing insulin usage during mealtime by patients. In addition, the drug improved glycemic control. Type 1 diabetes affects more than a million people worldwide. Let’s hope Phase 3 yields even better results.